See, R E <br/><br/>
Risperidone-induced increase of plasma norepinephrine is not correlated with symptom improvement in chronic schizophrenia.  [electronic resource] 

 -  Biological psychiatry  Jun 1999 
 - 1653-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-3223 
<br/><br/><label>Standard No.: </label>10.1016/s0006-3223(98)00199-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antipsychotic Agents--pharmacology<br/>Chronic Disease<br/>Double-Blind Method<br/>Female<br/>Haloperidol--pharmacology<br/>Humans<br/>Male<br/>Norepinephrine--blood<br/>Risperidone--pharmacology<br/>Schizophrenia--drug therapy<br/>Schizophrenic Psychology<br/>Treatment Outcome